BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 15027860)

  • 1. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
    Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
    J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.
    Arouri A; Mouritsen OG
    Eur J Pharm Sci; 2012 Mar; 45(4):408-20. PubMed ID: 21946258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue.
    Andresen TL; Jensen SS; Madsen R; Jørgensen K
    J Med Chem; 2005 Nov; 48(23):7305-14. PubMed ID: 16279790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids.
    Jensen SS; Andresen TL; Davidsen J; Høyrup P; Shnyder SD; Bibby MC; Gill JH; Jørgensen K
    Mol Cancer Ther; 2004 Nov; 3(11):1451-8. PubMed ID: 15542784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Packing characteristics of two-component bilayers composed of ester- and ether-linked phospholipids.
    Batenjany MM; O'Leary TJ; Levin IW; Mason JT
    Biophys J; 1997 Apr; 72(4):1695-700. PubMed ID: 9083673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR; Bittman R; Peters A; Mayhew E
    J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of polymerizable lipid bilayers. V. Synthesis, bilayer structure and properties of diacetylenic ether and ester lipids.
    Rhodes DG; Xu Z; Bittman R
    Biochim Biophys Acta; 1992 Sep; 1128(1):93-104. PubMed ID: 1390881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cascade liposomal triggering: light-induced Ca2+ release from diplasmenylcholine liposomes triggers PLA2-catalyzed hydrolysis and contents leakage from DPPC liposomes.
    Wymer NJ; Gerasimov OV; Thompson DH
    Bioconjug Chem; 1998; 9(3):305-8. PubMed ID: 9576803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer double lipid prodrugs: liposomal preparation and characterization.
    Arouri A; Mouritsen OG
    J Liposome Res; 2011 Dec; 21(4):296-305. PubMed ID: 21438721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of a lipid-membrane destabilizing enzyme with PEG-liposomes.
    Jørgensen K; Kiebler T; Hylander I; Vermehren C
    Int J Pharm; 1999 Jun; 183(1):21-4. PubMed ID: 10361147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs.
    Pedersen PJ; Christensen MS; Ruysschaert T; Linderoth L; Andresen TL; Melander F; Mouritsen OG; Madsen R; Clausen MH
    J Med Chem; 2009 May; 52(10):3408-15. PubMed ID: 19402667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1-palmitoyl-2-hexadecyl-sn-glycero-3-phosphocholine (PHPC).
    Duclos RI
    Chem Phys Lipids; 1993 Dec; 66(3):161-70. PubMed ID: 8111932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of association of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with liposomes is composition dependent.
    Mayhew E; Ahmad I; Bhatia S; Dause R; Filep J; Janoff AS; Kaisheva E; Perkins WR; Zha Y; Franklin JC
    Biochim Biophys Acta; 1997 Oct; 1329(1):139-48. PubMed ID: 9370251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamyl analogs of phosphatidylcholines. Synthesis, interaction with phospholipases and permeability behavior of their liposomes.
    Gupta CM; Bali A
    Biochim Biophys Acta; 1981 Feb; 663(2):506-15. PubMed ID: 7213783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretory phospholipase A2 hydrolysis of phospholipid analogues is dependent on water accessibility to the active site.
    Peters GH; Møller MS; Jørgensen K; Rönnholm P; Mikkelsen M; Andresen TL
    J Am Chem Soc; 2007 May; 129(17):5451-61. PubMed ID: 17419625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid-catalyzed plasmenylcholine hydrolysis and its effect on bilayer permeability: a quantitative study.
    Gerasimov OV; Schwan A; Thompson DH
    Biochim Biophys Acta; 1997 Mar; 1324(2):200-14. PubMed ID: 9092707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory phospholipase A₂ responsive liposomes.
    Zhu G; Mock JN; Aljuffali I; Cummings BS; Arnold RD
    J Pharm Sci; 2011 Aug; 100(8):3146-3159. PubMed ID: 21455978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an understanding of the release behavior of temperature-sensitive liposomes: a possible explanation of the "pseudoequilibrium" release behavior at the phase transition temperature.
    Zhang X; Luckham PF; Hughes AD; Thom S; Xu XY
    J Liposome Res; 2013 Sep; 23(3):167-73. PubMed ID: 23510297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.